GlassScriptPhysician profile
Christine Dalva
NPI 1942690599
$1,692.03
in general payments reported to CMS, 2019-2025
16 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.28 · 2022: $63.17 · 2023: $446 · 2024: $795 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,570.13 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $801.38 | 2022-2025 | |
| Lilly USA, LLC | $160.11 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Mimedx Group, INC. | $113.75 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $89.09 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $88.96 | 2024-2025 | Zoryve |
| Amgen INC. | $73.56 | 2023-2025 | Otezla |
| Ucb, INC. | $67.92 | 2024-2025 | Bimzelx |
| Organon LLC | $66.91 | 2021-2025 | Vtama |
| Genzyme Corporation | $64.39 | 2024-2025 | |
| Strata Skin Sciences, INC. | $41.83 | 2024 | Xtrac |
| Incyte Corporation | $29.92 | 2024 | Opzelura |
| Revance Therapeutics, INC. | $29.33 | 2024 | Daxxify |
| Dermavant Sciences, INC. | $24.19 | 2024 | Vtama |
| Roche Diagnostics Corporation | $14.59 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.55 | 2024 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Dalva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.